A double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of oravescent fentanyl citrate [fentanyl] for the management of breakthrough pain in opioid-tolerant patients with chronic neuropathic pain

Trial Profile

A double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of oravescent fentanyl citrate [fentanyl] for the management of breakthrough pain in opioid-tolerant patients with chronic neuropathic pain

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Jun 2014

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Neuropathic pain
  • Focus Registrational; Therapeutic Use
  • Sponsors Cephalon
  • Most Recent Events

    • 22 Sep 2006 Status change
    • 19 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top